Association of BRAF Variants With Disease Characteristics, Prognosis, and Targeted Therapy Response in Intrahepatic Cholangiocarcinoma
JAMA Network Open · 2023
DOI: 10.1001/jamanetworkopen.2023.1476 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA Network Open, 2023. Verfasst von Hao-Yang Xin und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Liver Surgery and Transplantation, Zhongshan Hospital, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Bile Duct Neoplasms, Cholangiocarcinoma, Proto-Oncogene Proteins B-raf. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Importance BRAF variants are associated with tumor progression; however, the prevalence of BRAF variant subtypes and their association with disease characteristics, prognosis, and targeted therapy response in patients with intrahepatic cholangiocarcinoma (ICC) are largely unknown.
Objective
To explore the association of BRAF variant subtypes with disease characteristics, prognosis, and targeted therapy response in patients with ICC. Design, Setting, and Participants In this cohort study, 1175 patients who underwent curative resection for ICC from January 1, 2009, through December 31, 2017, were evaluated at a single hospital in China. Whole-exome sequencing, targeted sequencing, and Sanger sequencing were performed to identify BRAF variants. The Kaplan-Meier method and log-rank test were used to compare overall survival (OS) and disease-free survival (DFS). Univariate and multivariate analyses were performed using Cox proportional hazards regression. Associations between BRAF variants and targeted therapy response were tested in 6 BRAF -variant, patient-derived organoid lines and in 3 of the patient donors of those lines. Data were analyzed from June 1, 2021, to March 15, 2022.
Interventions
Hepatectomy in patients with ICC. Main Outcomes and Measures The association of BRAF variant subtypes with OS and DFS.
Results
Of 1175 patients with ICC, the mean (SD) age was 59.4 (10.4) years and 701 (59.7%) were men. A total of 20 different subtypes of BRAF somatic variance affecting 49 patients (4.2%) were identified; V600E was the most frequent allele in this cohort, accounting for 27% of the identified BRAF variants, followed by K601E (14%), D594G (12%), and N581S (6%). Compared with patients with non-V600E BRAF variants, patients with BRAF V600E variants were more likely to have large tumor size (10 of 13 [77%] vs 12 of 36 [33%]; P = .007), multiple tumors (7 of 13 [54%] vs 8 of 36 [22%]; P = .04), and more vascular/bile duct invasion (7 of 13 [54%] vs 8 of 36 [22%]; P = .04). Multivariate analysis revealed that BRAF V600E variants, but not overall BRAF variants or non-V600E BRAF variants, were associated with poor OS (hazard ratio [HR], 1.87; 95% CI, 1.05-3.33; P = .03) and DFS (HR, 1.66; 95% CI, 1.03-2.97; P = .04). There were also broad differences among organoids with different BRAF variant subtypes in sensitivity to BRAF or MEK inhibitors. Conclusions and Relevance The findings of this cohort study suggest that there are broad differences among organoids with different BRAF variant subtypes in sensitivity to BRAF or MEK inhibitors. Identifying and classifying BRAF variants may be able to help guide precise treatment for patients with ICC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Liver Surgery and Transplantation, Zhongshan Hospital, Fudan University, Shanghai, China.
- Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China.
Zitieren
APA
Xin, H. Y., Sun, R. Q., Zou, J. X., Wang, P. C., Wang, J. Y., Ye, Y. H., Liu, K. X., Hu, Z. Q., Zhou, Z. J., Fan, J., Zhou, J., & Zhou, S. L. (2023). Association of BRAF Variants With Disease Characteristics, Prognosis, and Targeted Therapy Response in Intrahepatic Cholangiocarcinoma. JAMA Network Open. https://doi.org/10.1001/jamanetworkopen.2023.1476
Vancouver
Xin HY, Sun RQ, Zou JX, Wang PC, Wang JY, Ye YH, et al. Association of BRAF Variants With Disease Characteristics, Prognosis, and Targeted Therapy Response in Intrahepatic Cholangiocarcinoma. JAMA Network Open. 2023. doi:10.1001/jamanetworkopen.2023.1476
BibTeX
@article{Xin2023,
author = {Xin, Hao-Yang and Sun, Rong-Qi and Zou, Ji-Xue and Wang, Peng-Cheng and Wang, Jia-Yin and Ye, Yu-Hang and Liu, Kai-Xuan and Hu, Zhi-Qiang and Zhou, Zheng-Jun and Fan, Jia and Zhou, Jian and Zhou, Shao-Lai},
title = {Association of BRAF Variants With Disease Characteristics, Prognosis, and Targeted Therapy Response in Intrahepatic Cholangiocarcinoma},
journal = {JAMA Network Open},
year = {2023},
doi = {10.1001/jamanetworkopen.2023.1476}
}
EUVIMED